Two Israeli studies showed that vaccine boosters reduced rates of infection and severe disease. Experts gathered for the seventh ACP and Annals of Internal Medicine virtual forum on COVID-19. The FDA authorized a monoclonal antibody for pre-exposure prophylaxis in certain patients.
Among glucagon-like peptide-1 receptor agonists, semaglutide appeared to be the most effective for weight loss, with a higher likelihood of weight loss of 5% or more and percentage body weight change and a similar risk of adverse events.
A 58-year-old man is evaluated during a routine visit. He has psoriatic arthritis and hypertension. Following a physical exam and lab studies, what is the most appropriate treatment?
Patients taking an angiotensin receptor-neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter-2 inhibitor showed the greatest reduction in risk of death, the analysis of heart failure with reduced ejection fraction found.
The College's Mentoring Resource Library is now available for all members, and a monthly online Peer Mentoring Session series is specifically geared toward early-career physicians and ACP Resident/Fellow Members.
ACP's Executive Committee of the Board of Governors announces Class of 2027 Governor-elect Designees
The Governor-elect Designees will start their terms as Governors-elect after the College's Annual Business Meeting on April 30, 2022, and will take office as Governors in April 2023.